Home Advertisement

Home uncategorized Hepatitis B

Hepatitis B

General features:

• It is an DNA virus from the Hepadnavirus family. The incubation period is 30-180 (average 80) days.

• The risk of becoming chronic is directly proportional to the early receipt of the virus.

• There is a risk of 90% of perinatal infection, 20-50% of infection at 1-5 years of age, and 1-5% of infection acquired in adulthood.

Transmission routes:

• Vertical transmission: The risk of infection in the baby born to an HBeAg (+) mother is 90%.

• Horizontal transfer: The most common way of lateral transfer in adults is sexual intercourse and intravenous drug addiction.

• Transfusion by transfusion: It is very rare today as blood products are routinely screened.

Clinical features:

• Most of the cases are asymptomatic.

• In symptomatic cases, the clinic is typical acute viral hepatitis.

• The best indicator of prognosis is prothrombin time.

• The majority of cases with acute hepatitis B in adulthood recover fully by developing immunity.

• 0.1%-1% of cases with acute hepatitis B may progress with liver failure in the form of fulminant hepatitis, and they have a high mortality risk.

HBV Extrahepatic findings

Gianotti Crosty syndrome (maculopapular rash)

Serum sickness-like syndrome

Arthritis

Polyarteritis nodosa

Mixed cryoglobulinemia

aplastic anemia

membranous glomerulonephritis

Diagnosis

hepatitis B surface antigen HBsAG and its antibody Anti-HBs:

The first antigen detected in the blood is HBsAg.

After HBsAg becomes negative, anti-HBs emerges and shows natural immunity.

Hepatitis B core antigen HBcAg:

It is an antigen found only in infected hepatocytes; not detected in serum.

Anti-HBc IgM:

It is the best indicator of acute hepatitis.

The period between the disappearance of HBsAg and the formation of anti-HBs in the course of acute hepatitis B is called the window period. During this period, HBsAg and anti-HBs are negative, while anti-HBc IgM is positive.

Anti-HBc IgG:

Indicates that you have been exposed to the hepatitis B virus at some point in your life.

HBeAg:

HBV is an indicator of replication and infectivity.

With a mutation occurring in the precore region of the virus, HBeAg cannot be synthesized and is found negative despite replication. This is called a precore mutant virus (recognized by negative HBeAg while HBV DNA is high in serum).

• Anti-HBe:

It is the antibody synthesized against HBeAg and suppresses the infectivity.

• HBV DNA:

It is the most important determinant of viral replication.

Protection:
• Vaccination: It is given at 0, 1 and 6 months.
An individual who has completed 3 doses (0, 1 and 6 months) of the normal vaccination schedule is considered to have responded if the anti-HBs titer is >10 mlU/ml in the test performed 1-2 months later.
Again, even if it is an acute exposure to this person; No need for anti-HBs testing, booster or immunoglobulin.
Even if anti-HBs < 10 mIU/mL is tested in a person with a known vaccine response, no booster or other action is required. The only exception is patients with immunodeficiency.
In a patient who has been vaccinated before but whose antibody titer has not been checked, the titer is measured after exposure. If anti-HBs < 10 mIU/mL, vaccine and immunoglobulin are administered.
If the anti-HBs titer is <10 mlU/mL in the test performed 1-2 months after the hepatitis B vaccination scheme, this person is unresponsive and a double dose vaccination scheme is administered once again. If there is an acute exposure at this time, immunoglobulin is also required. Again, in patients whose antibody titer does not increase, vaccination is not insisted on again.
• Hepatitis B immunoglobulin:
Immunoglobulin is administered immediately (preferably within the first 24 hours) after inoculation or contact of HBsAg positive material in an unvaccinated or vaccine unresponsive adult.
Treatment:
• Supportive treatment in acute viral hepatitis B unless it is basically complicated
is applied.
• Antiviral agents (entecavir or tenofovir) can be given in severe hepatitis.
Edit post
Back to top button